Free Trial

BKV (NYSE:BKV) Now Covered by Susquehanna

BKV logo

Investment analysts at Susquehanna initiated coverage on shares of BKV (NYSE:BKV - Get Free Report) in a research report issued to clients and investors on Tuesday, MarketBeat.com reports. The firm set a "positive" rating and a $24.00 price target on the stock. Susquehanna's price target suggests a potential upside of 30.72% from the company's current price.

A number of other brokerages also recently commented on BKV. Evercore ISI assumed coverage on BKV in a research report on Monday. They issued an "outperform" rating and a $24.00 price objective for the company. Barclays started coverage on shares of BKV in a research note on Monday. They set an "overweight" rating and a $24.00 price target on the stock. Jefferies Financial Group started coverage on shares of BKV in a research note on Monday. They issued a "buy" rating and a $28.00 price objective for the company. Mizuho started coverage on shares of BKV in a report on Monday. They set an "outperform" rating and a $29.00 price objective for the company. Finally, Citigroup started coverage on shares of BKV in a research note on Monday. They issued a "buy" rating and a $29.00 target price on the stock. Seven research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $25.86.

View Our Latest Analysis on BKV

BKV Trading Down 0.7 %

Shares of NYSE BKV traded down $0.13 during mid-day trading on Tuesday, hitting $18.36. The company had a trading volume of 138,247 shares, compared to its average volume of 465,219. BKV has a 12 month low of $17.90 and a 12 month high of $18.88.

Insider Buying and Selling

In other news, insider Mary Rita Valois purchased 2,000 shares of BKV stock in a transaction on Friday, September 27th. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $36,000.00. Following the completion of the transaction, the insider now directly owns 15,333 shares in the company, valued at approximately $275,994. This represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other BKV news, insider Mary Rita Valois acquired 2,000 shares of the business's stock in a transaction on Friday, September 27th. The stock was purchased at an average price of $18.00 per share, for a total transaction of $36,000.00. Following the transaction, the insider now owns 15,333 shares in the company, valued at $275,994. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO John T. Jimenez bought 16,500 shares of the firm's stock in a transaction dated Friday, September 27th. The shares were acquired at an average price of $18.00 per share, for a total transaction of $297,000.00. Following the acquisition, the chief financial officer now directly owns 273,274 shares of the company's stock, valued at approximately $4,918,932. The trade was a 0.00 % increase in their position. The disclosure for this purchase can be found here. Insiders bought 21,850 shares of company stock worth $393,300 in the last quarter.

About BKV

(Get Free Report)

BKV Corporation engages in the acquisition, operation, and development of natural gas and NGL properties. It is also involved in the gathering, processing, and transportation of natural gas. The company was founded in 2015 and is based in Denver, Colorado with additional offices in Tunkhannock, Pennsylvania and Fort Worth, Texas.

Read More

Analyst Recommendations for BKV (NYSE:BKV)

Should you invest $1,000 in BKV right now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet Gaining Momentum: Can It Reach $200 by December?

Alphabet (GOOGL) is in the midst of a year-end rally, climbing 10% since September, and some analysts predict it could gain another 30% by Christmas!

Recent Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
Build-to-Order: The Strategy Fueling Toll Brothers’ Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines